Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis
2009 · Arthritis Research & Therapy · 114 citations
https://doi.org/10.1186/ar2706
W
Wolfgang Hueber
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
6.7K
Citations
27
h-index
32
i10-index
Wolfgang Hueber is an academic researcher from Novartis (Switzerland). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Systemic Lupus Erythematosus Research & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 27, co-authored 67 publications.
Papers by this author
worksDevelopment and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome
2022 · Annals of the Rheumatic Diseases · 78 citations
https://doi.org/10.1136/annrheumdis-2021-222054
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
2024 · The Lancet · 39 citations
https://doi.org/10.1016/s0140-6736(24)01211-x
Content Validity of Sjögren’s Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren’s
2022 · Rheumatology and Therapy · 11 citations
https://doi.org/10.1007/s40744-022-00489-y
Primary Sjögren’s Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
2025 · Annals of the Rheumatic Diseases · 9 citations
https://doi.org/10.1016/j.ard.2025.05.004
Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren’s
2022 · Rheumatology and Therapy · 7 citations
https://doi.org/10.1007/s40744-022-00487-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat